Determined by SDS-PAGE, the purity of the protein is greater than 95%.

When Recombinant Human CD123/His Protein is immobilized at 2μg/mL (100 μL/well), the concentration of Anti-Human IL-3RA(Pivekimab) that produces 50% of the optimal binding response is approximately 0.1 ug/ml.

Anti-Human IL-3RA(Pivekimab)（Cat.No.B21679601）captured on Protein A chip , can bind Recombinant Human CD123/His Protein（Cat.No.B21677403） with a KD constant of 1.01E-10 M, determined in a SPR assay .